Long-Term Trial Data Show Triplet Therapy Extends Survival in Metastatic Prostate Cancer
Long-term PEACE-1 trial results show that adding abiraterone to ADT and docetaxel reduced the risk of death by 32 percent ...
Long-term PEACE-1 trial results show that adding abiraterone to ADT and docetaxel reduced the risk of death by 32 percent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine